当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析

康缘药业

(600557)

  

流通市值:109.16亿  总市值:110.34亿
流通股本:5.78亿   总股本:5.85亿

康缘药业(600557)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.50亿元,每股收益0.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益550935.84万元,未分配利润439962.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产737997.12万元,负债187061.28万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,359,020,285.934,867,806,702.43,496,031,021.852,553,167,904.18
营业总成本1,187,013,990.734,359,915,092.723,101,831,386.372,233,196,147.97
营业利润182,594,683.81563,792,393.22447,063,761.42342,229,117.5
利润总额177,601,538.14550,982,603.37435,042,909.35334,746,398.79
净利润149,567,584.88547,050,271.78359,753,803.62282,889,034.97
其他综合收益----
综合收益总额149,567,584.88547,050,271.78359,753,803.62282,889,034.97
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计4,222,203,715.694,049,719,426.383,631,010,304.813,771,501,855.17
非流动资产合计3,157,767,457.513,067,602,241.143,064,857,570.413,032,851,520.74
资产总计7,379,971,173.27,117,321,667.526,695,867,875.226,804,353,375.91
流动负债合计1,714,116,520.031,608,688,119.361,430,606,229.111,614,610,036.88
非流动负债合计156,496,236.01128,080,808.2878,544,391.0779,890,852.64
负债合计1,870,612,756.041,736,768,927.641,509,150,620.181,694,500,889.52
归属于母公司股东权益合计5,326,721,847.475,192,797,030.754,999,051,386.424,925,246,004.02
股东权益合计5,509,358,417.165,380,552,739.885,186,717,255.045,109,852,486.39
负债和股东权益合计7,379,971,173.27,117,321,667.526,695,867,875.226,804,353,375.91
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,476,423,811.85,775,649,064.144,327,293,292.922,979,346,456.08
经营活动现金流出小计1,277,555,884.914,734,645,214.253,553,562,903.592,522,979,923.65
经营活动产生的现金流量净额198,867,926.891,041,003,849.89773,730,389.33456,366,532.43
投资活动现金流入小计517,789,654.581,069,174,484.8446,882,281.77137,279,392.44
投资活动现金流出小计623,276,787.321,609,480,998.281,196,777,125.32215,267,699.69
投资活动产生的现金流量净额-105,487,132.74-540,306,513.48-749,894,843.55-77,988,307.25
筹资活动现金流入小计-4,858,700--
筹资活动现金流出小计16,479,528.36134,671,199.44130,969,189.442,357,640
筹资活动产生的现金流量净额-16,479,528.36-129,812,499.44-130,969,189.44-2,357,640
汇率变动对现金及现金等价物的影响-61,773.6--
现金及现金等价物净增加额76,901,265.79370,946,610.57-107,133,643.66376,020,585.18
期末现金及现金等价物余额2,046,174,149.111,972,246,441.561,494,166,187.331,977,320,416.17
最新报告期:2024-04-19
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
万联证券黄婧婧1.101.331.612024-04-19
中邮证券古意涵,蔡明子1.111.341.592024-04-16
东方财富证券何玮1.071.291.482024-04-15
华泰证券代雯,张云逸,高初蕾1.121.371.662024-04-14
国联证券郑薇1.101.401.602024-04-14
TOP↑